Published in J Am Pharm Assoc (2003) on June 08, 2017
Osteoporosis prevention, diagnosis, and therapy. JAMA (2001) 12.60
Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res (1999) 9.85
Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc (2006) 5.32
US pharmacists' effect as team members on patient care: systematic review and meta-analyses. Med Care (2010) 4.65
Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK. Osteoporos Int (2008) 3.44
The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int (2004) 2.88
Assessment of compliance with osteoporosis treatment and its consequences in a managed care population. Bone (2005) 2.66
The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res (2014) 2.52
Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis. Mayo Clin Proc (2007) 2.43
Impact of osteoporosis treatment adherence on fracture rates in North America and Europe. Am J Med (2009) 2.27
Predictors of adherence to diabetes medications: the role of disease and medication beliefs. J Behav Med (2009) 2.12
Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women. Mayo Clin Proc (2005) 2.07
Consumer-oriented interventions for evidence-based prescribing and medicines use: an overview of systematic reviews. Cochrane Database Syst Rev (2011) 1.88
Benefit of adherence with bisphosphonates depends on age and fracture type: results from an analysis of 101,038 new bisphosphonate users. J Bone Miner Res (2008) 1.47
Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review. Ann Pharmacother (2005) 1.23
Maternal predictors of neonatal bone size and geometry: the Southampton Women's Survey. J Dev Orig Health Dis (2010) 1.20
Challenges for improving medication adherence. JAMA (2006) 1.18
The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates. Curr Med Res Opin (2007) 1.17
Improving adherence and clinical outcomes through an HIV pharmacist's interventions. AIDS Care (2010) 1.16
Factors affecting long-term compliance of osteoporotic patients with bisphosphonate treatment and QOL assessment in actual practice: alendronate and risedronate. J Bone Miner Metab (2007) 1.11
Nonadherence and osteoporosis treatment preferences of older women: a qualitative study. J Womens Health (Larchmt) (2003) 1.09
The PAADRN study: a design for a randomized controlled practical clinical trial to improve bone health. Contemp Clin Trials (2012) 1.09
Patients' adherence to osteoporosis therapy: exploring the perceptions of postmenopausal women. Can Fam Physician (2008) 1.08
Trends in Media Reports, Oral Bisphosphonate Prescriptions, and Hip Fractures 1996-2012: An Ecological Analysis. J Bone Miner Res (2015) 1.07
Estimating bisphosphonate use and fracture reduction among US women aged 45 years and older, 2001-2008. J Bone Miner Res (2011) 1.07
Patient-focused intervention to improve long-term adherence to evidence-based medications: a randomized trial. Am Heart J (2012) 1.06
Differences in persistence among different weekly oral bisphosphonate medications. Osteoporos Int (2008) 1.02
Pharmacist telemonitoring of antidepressant use: effects on pharmacist-patient collaboration. J Am Pharm Assoc (2003) (2005) 1.02
The impact of pharmacist face-to-face counseling to improve medication adherence among patients initiating statin therapy. Patient Prefer Adherence (2012) 1.01
Factors contributing to compliance with osteoporosis medication. Isr Med Assoc J (2008) 0.99
Assessing the effectiveness of pharmacy-based adherence interventions on antiretroviral adherence in persons with HIV. AIDS Patient Care STDS (2011) 0.97
Long-term impact of adherence to oral bisphosphonates on osteoporotic fracture incidence. J Bone Miner Res (2012) 0.94
Measuring and improving adherence to osteoporosis pharmacotherapy. Curr Opin Rheumatol (2010) 0.93
Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice. Ann Pharmacother (2009) 0.93
A pharmaceutical care program to improve adherence to statin therapy: a randomized controlled trial. Ann Pharmacother (2010) 0.89
Association between patient beliefs and medication adherence following hospitalization for acute coronary syndrome. Am Heart J (2011) 0.88
Proactive pharmaceutical care interventions decrease patients' nonadherence to osteoporosis medication. Osteoporos Int (2014) 0.87
Medication monitoring and optimization: a targeted pharmacist program for effective and cost-effective improvement of chronic therapy adherence. J Manag Care Spec Pharm (2014) 0.87
Patient-activation and guideline-concordant pharmacological treatment after bone density testing: the PAADRN randomized controlled trial. Osteoporos Int (2016) 0.86
Effects of a DXA result letter on satisfaction, quality of life, and osteoporosis knowledge: a randomized controlled trial. BMC Musculoskelet Disord (2016) 0.86
Improving bone mineral density reporting to patients with an illustration of personal fracture risk. BMC Med Inform Decis Mak (2014) 0.84
The necessity-concerns framework predicts adherence to medication in multiple illness conditions: A meta-analysis. Patient Educ Couns (2015) 0.84
Understanding the associations between modifying factors, individual health beliefs, and hemodialysis patients' adherence to a low-phosphorus diet. J Ren Nutr (2014) 0.82
Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: a quasi-experimental study. Nephrol Dial Transplant (2014) 0.80
Diabetes transitional care from inpatient to outpatient setting: pharmacist discharge counseling. J Pharm Pract (2012) 0.79
Activating Patients With a Tailored Bone Density Test Results Letter and Educational Brochure: the PAADRN Randomized Controlled Trial. J Clin Densitom (2016) 0.78
Strategies to improve adherence with medications in chronic, 'silent' diseases representing high cardiovascular risk. Expert Rev Pharmacoecon Outcomes Res (2006) 0.77
2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) (2012) 12.07
Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum (2004) 4.77
American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken) (2010) 4.65
Availability of consumer prices from US hospitals for a common surgical procedure. JAMA Intern Med (2013) 4.35
Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls. Am J Gastroenterol (2008) 3.95
The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings. Ann Intern Med (2011) 3.80
2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken) (2011) 3.66
Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases. JAMA (2011) 3.58
Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res (Hoboken) (2012) 3.47
Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists. Arthritis Rheum (2007) 3.38
Automated external defibrillators and survival after in-hospital cardiac arrest. JAMA (2010) 3.36
Gout medication treatment patterns and adherence to standards of care from a managed care perspective. Mayo Clin Proc (2006) 2.96
Effects of computerized guidelines for managing heart disease in primary care. J Gen Intern Med (2003) 2.96
Associations between reduced hospital length of stay and 30-day readmission rate and mortality: 14-year experience in 129 Veterans Affairs hospitals. Ann Intern Med (2012) 2.92
The costs of critical care telemedicine programs: a systematic review and analysis. Chest (2013) 2.75
The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res (2014) 2.52
Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. JAMA (2012) 2.51
Coffee, tea, and caffeine consumption and risk of rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum (2002) 2.43
A comparison of clinically important differences in health-related quality of life for patients with chronic lung disease, asthma, or heart disease. Health Serv Res (2005) 2.35
Impact of osteoporosis treatment adherence on fracture rates in North America and Europe. Am J Med (2009) 2.27
Administrative codes combined with medical records based criteria accurately identified bacterial infections among rheumatoid arthritis patients. J Clin Epidemiol (2008) 2.25
Clinical value of monitoring BMD in patients treated with bisphosphonates for osteoporosis. J Bone Miner Res (2009) 2.24
The effect of adverse housing and neighborhood conditions on the development of diabetes mellitus among middle-aged African Americans. Am J Epidemiol (2007) 2.17
Failure of computerized treatment suggestions to improve health outcomes of outpatients with uncomplicated hypertension: results of a randomized controlled trial. Pharmacotherapy (2004) 2.17
Rates of malignancy associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum (2012) 2.15
Initiation of anti-TNF therapy and the risk of optic neuritis: from the safety assessment of biologic ThERapy (SABER) Study. Am J Ophthalmol (2012) 2.14
Risk factors for late-life suicide: a prospective, community-based study. Am J Geriatr Psychiatry (2002) 2.13
Relation between hospital orthopaedic specialisation and outcomes in patients aged 65 and older: retrospective analysis of US Medicare data. BMJ (2010) 2.08
The Cardiovascular Research Network: a new paradigm for cardiovascular quality and outcomes research. Circ Cardiovasc Qual Outcomes (2008) 2.03
Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy. Arthritis Care Res (Hoboken) (2015) 2.03
The aftermath of hip fracture: discharge placement, functional status change, and mortality. Am J Epidemiol (2009) 2.02
Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs. Pharmacoepidemiol Drug Saf (2013) 2.01
Cigarette smoking and the risk of rheumatoid arthritis among postmenopausal women: results from the Iowa Women's Health Study. Am J Med (2002) 2.01
Medication errors among adults and children with cancer in the outpatient setting. J Clin Oncol (2008) 2.00
Obesity is not protective against fracture in postmenopausal women: GLOW. Am J Med (2011) 1.95
Trends in the use of biologic agents among rheumatoid arthritis patients enrolled in the US medicare program. Arthritis Care Res (Hoboken) (2013) 1.92
Toward patient-centered cancer care: patient perceptions of problematic events, impact, and response. J Clin Oncol (2012) 1.91
Can computer-generated evidence-based care suggestions enhance evidence-based management of asthma and chronic obstructive pulmonary disease? A randomized, controlled trial. Health Serv Res (2005) 1.91
The association between hospital obstetrical volume and maternal postpartum complications. Am J Obstet Gynecol (2012) 1.90
Comparison of weekly treatment of postmenopausal osteoporosis with alendronate versus risedronate over two years. J Clin Endocrinol Metab (2006) 1.88
Medication errors in the home: a multisite study of children with cancer. Pediatrics (2013) 1.87
Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Rheum (2006) 1.85
Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone (2012) 1.79
Osteoporosis or low bone mass at the femur neck or lumbar spine in older adults: United States, 2005-2008. NCHS Data Brief (2012) 1.79
Clinically relevant levels of depressive symptoms in community-dwelling middle-aged African Americans. J Am Geriatr Soc (2004) 1.78
Gastrointestinal symptoms and glycemic control in diabetes mellitus: a longitudinal population study. Eur J Gastroenterol Hepatol (2008) 1.78
Quality of care indicators for gout management. Arthritis Rheum (2004) 1.77
Measuring quality in arthritis care: methods for developing the Arthritis Foundation's quality indicator set. Arthritis Rheum (2004) 1.76
Randomized trial to improve fracture prevention in nursing home residents. Am J Med (2007) 1.75
Financial payments by orthopedic device makers to orthopedic surgeons. Arch Intern Med (2011) 1.74
Inner city, middle-aged African Americans have excess frank and subclinical disability. J Gerontol A Biol Sci Med Sci (2005) 1.74
Clinically important changes in health-related quality of life for patients with chronic obstructive pulmonary disease: an expert consensus panel report. J Gen Intern Med (2003) 1.70
Clinically important differences in health-related quality of life for patients with asthma: an expert consensus panel report. Ann Allergy Asthma Immunol (2003) 1.70
Neighborhood conditions and risk of incident lower-body functional limitations among middle-aged African Americans. Am J Epidemiol (2006) 1.66
Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users. Pharmacoepidemiol Drug Saf (2006) 1.65
Impact of prevalent fractures on quality of life: baseline results from the global longitudinal study of osteoporosis in women. Mayo Clin Proc (2010) 1.62
Validity of gout diagnoses in administrative data. Arthritis Rheum (2007) 1.62
Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW). J Bone Miner Res (2014) 1.62
Acute myocardial infarction and congestive heart failure outcomes at specialty cardiac hospitals. Circulation (2007) 1.61
Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients. Arthritis Rheum (2005) 1.58
The epidemiology of glucocorticoid-associated adverse events. Curr Opin Rheumatol (2008) 1.58
Forceps delivery volumes in teaching and nonteaching hospitals: are volumes sufficient for physicians to acquire and maintain competence? Acad Med (2014) 1.55
Longitudinal trends in use of bone mass measurement among older americans, 1999-2005. J Bone Miner Res (2008) 1.55
GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol (2002) 1.53
Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study. Arthritis Care Res (Hoboken) (2012) 1.53
Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritis. Arthritis Res Ther (2011) 1.53
Racial differences in admissions to high-quality hospitals for coronary heart disease. Arch Intern Med (2010) 1.53
Insurance status and the transfer of hospitalized patients: an observational study. Ann Intern Med (2014) 1.49
Performance evaluation of a multiplex assay for future use in biomarker discovery efforts to predict body composition. Clin Chem Lab Med (2011) 1.48
Fee-based care is important for access to prompt treatment of hip fractures among veterans. Clin Orthop Relat Res (2013) 1.47
OMERACT 6 brings new perspectives to rheumatology measurement research. J Rheumatol (2003) 1.47
Benefit of adherence with bisphosphonates depends on age and fracture type: results from an analysis of 101,038 new bisphosphonate users. J Bone Miner Res (2008) 1.47
Blood transfusion, alcohol use, and anthropometric risk factors for rheumatoid arthritis in older women. J Rheumatol (2002) 1.46
Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster. JAMA (2013) 1.45
Clinical predictors of Barrett's esophagus length. Gastrointest Endosc (2005) 1.45
Identification and validation of vertebral compression fractures using administrative claims data. Med Care (2009) 1.45
Recent trends in hip fracture rates by race/ethnicity among older US adults. J Bone Miner Res (2012) 1.44
Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum (2012) 1.43
Predictors of turnover of lower gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol (2002) 1.42
The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents. Ann Rheum Dis (2011) 1.42
Empirically based composite fracture prediction model from the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW). J Clin Endocrinol Metab (2014) 1.41
Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trial. Arch Intern Med (2007) 1.41
Teeth with large amalgam restorations and crowns: factors affecting the receipt of subsequent treatment after 10 years. J Am Dent Assoc (2005) 1.40
Adverse outcomes in hip arthroplasty: long-term trends. J Bone Joint Surg Am (2012) 1.40
Effect of memory impairment on training outcomes in ACTIVE. J Int Neuropsychol Soc (2007) 1.40
Population-based fracture risk assessment and osteoporosis treatment disparities by race and gender. J Gen Intern Med (2009) 1.40
Using the standard error of measurement to identify important changes on the Asthma Quality of Life Questionnaire. Qual Life Res (2002) 1.39
The impact of hospital cardiac specialization on outcomes after coronary artery bypass graft surgery: analysis of medicare claims data. Circ Cardiovasc Qual Outcomes (2010) 1.39
Dental care after an emergency department visit for dental problems among adults enrolled in Medicaid. J Am Dent Assoc (2015) 1.39
Antioxidant micronutrients and risk of rheumatoid arthritis in a cohort of older women. Am J Epidemiol (2003) 1.35
Patients' and family members' views on patient-centered communication during cancer care. Psychooncology (2013) 1.35
Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2). Ann Rheum Dis (2012) 1.31
Improving the prediction of medication compliance: the example of bisphosphonates for osteoporosis. Med Care (2009) 1.31
Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems. Pharmacoepidemiol Drug Saf (2011) 1.30
Previous fractures at multiple sites increase the risk for subsequent fractures: the Global Longitudinal Study of Osteoporosis in Women. J Bone Miner Res (2012) 1.29
Translating primary care practice climate into patient activation: the role of patient trust in physician. Med Care (2008) 1.28
Clinically important differences in health status for patients with heart disease: an expert consensus panel report. Am Heart J (2004) 1.27
Central DXA utilization shifts from office-based to hospital-based settings among medicare beneficiaries in the wake of reimbursement changes. J Bone Miner Res (2012) 1.27